Lakefront Biotherapeutics NV (XTER:GXE) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:GXE Lakefront Biotherapeutics NV XTER:GXE
51 GF Score
Price €25.72
GF Value €109.30
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Lakefront Biotherapeutics NV Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTER:GXE vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Lakefront Biotherapeutics NV's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lakefront Biotherapeutics NV Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lakefront Biotherapeutics NV's Short Interest distribution charts can be found below:

* The bar in red indicates where Lakefront Biotherapeutics NV's Short Interest falls into.


XTER:GXE
51GF Score
Lakefront Biotherapeutics NV XTER:GXE
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lakefront Biotherapeutics NV (XTER:GXE) Overvalued in 2026?

Based on GuruFocus' analysis, Lakefront Biotherapeutics NV stock appears to be undervalued. The current stock price of €25.72 is trading 76.5% below its estimated GF Value™ of €109.30. GuruFocus considers Lakefront Biotherapeutics NV to be Possible Value Trap.

Key valuation signals for XTER:GXE:

  • Short Interest:
  • GF Value™: €109.30 vs. price of €25.72 (76.5% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the XTER:GXE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lakefront Biotherapeutics NV Business Description

Address Schalienhoevedreef 20 T, Mechelen, BEL, 2800
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
51GF Score

Get the complete analysis for XTER:GXE

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.72
Price
€109.30
GF Value